Related Articles
Bortezomib improves adoptive carbonic anhydrase IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinoma
Preclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinoma
Prognostic and therapeutic value of CD103+ cells in renal cell carcinoma
Association of RGS20 expression with the progression and prognosis of renal cell carcinoma
Chloroquine potentiates the anticancer effect of sunitinib on renal cell carcinoma by inhibiting autophagy and inducing apoptosis Corrigendum in /10.3892/ol.2024.14403